234 related articles for article (PubMed ID: 37016095)
1. Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights.
Abdallah HY; Faisal S; Tawfik NZ; Soliman NH; Kishk RM; Ellawindy A
Mol Diagn Ther; 2023 May; 27(3):405-423. PubMed ID: 37016095
[TBL] [Abstract][Full Text] [Related]
2. Serum miRNA expression profiles change in autoimmune vitiligo in mice.
Shi YL; Weiland M; Lim HW; Mi QS; Zhou L
Exp Dermatol; 2014 Feb; 23(2):140-2. PubMed ID: 24401108
[TBL] [Abstract][Full Text] [Related]
3. The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases-A Review.
Dopytalska K; Czaplicka A; Szymańska E; Walecka I
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298095
[TBL] [Abstract][Full Text] [Related]
4. Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo.
Abdallah HY; Abdelhamid NR; Mohammed EA; AbdElWahab NY; Tawfik NZ; Gomaa AHA; Toraih EA; Ellawindy A
Sci Rep; 2022 Aug; 12(1):13526. PubMed ID: 35941163
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis.
Das D; Akhtar S; Kurra S; Gupta S; Sharma A
Cytokine Growth Factor Rev; 2019 Feb; 45():35-44. PubMed ID: 30773437
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of four miRNA (miR-1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients.
Shang Z; Li H
J Dermatol; 2017 Oct; 44(10):1138-1144. PubMed ID: 28500632
[TBL] [Abstract][Full Text] [Related]
7. Dissecting genetics of cutaneous miRNA in a mouse model of an autoimmune blistering disease.
Gupta Y; Möller S; Witte M; Belheouane M; Sezin T; Hirose M; Vorobyev A; Niesar F; Bischof J; Ludwig RJ; Zillikens D; Sadik CD; Restle T; Häsler R; Baines JF; Ibrahim SM
BMC Genomics; 2016 Feb; 17():112. PubMed ID: 26879236
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA PRINS-miRNA-mRNA Axis Gene Expression Profile as a Circulating Biomarker Panel in Psoriasis.
Abdallah HY; Tawfik NZ; Soliman NH; Eldeen LAT
Mol Diagn Ther; 2022 Jul; 26(4):451-465. PubMed ID: 35761165
[TBL] [Abstract][Full Text] [Related]
9. Identifying the differentially expressed microRNAs in autoimmunity: A systemic review and meta-analysis.
Zhang L; Wu H; Zhao M; Lu Q
Autoimmunity; 2020 May; 53(3):122-136. PubMed ID: 31902241
[TBL] [Abstract][Full Text] [Related]
10. miRNA signatures and transcriptional regulation of their target genes in vitiligo.
Mansuri MS; Singh M; Begum R
J Dermatol Sci; 2016 Oct; 84(1):50-58. PubMed ID: 27450903
[TBL] [Abstract][Full Text] [Related]
11. Plasma MicroRNA Expression Profiles in Psoriasis.
Xiao S; Liu X; Wang X; Lv H; Zhao J; Guo X; Xian F; Ji Y; Zhang G
J Immunol Res; 2020; 2020():1561278. PubMed ID: 32411787
[TBL] [Abstract][Full Text] [Related]
12. Serum miRNA profiling identified miRNAs associated with disease severity in psoriasis.
Ganguly T; Laha S; Senapati S; Chatterjee G; Chatterjee R
Exp Dermatol; 2024 Jan; 33(1):e14973. PubMed ID: 37926911
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs: Emerging players in the pathogenesis of vitiligo.
Yu X; Cui Y; Zhu X; Xu H; Li L; Gao G
Front Cell Dev Biol; 2022; 10():964982. PubMed ID: 36187493
[TBL] [Abstract][Full Text] [Related]
14. Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases.
Czarnowicki T; He H; Leonard A; Kim HJ; Kameyama N; Pavel AB; Li R; Estrada Y; Wen HC; Kimmel GW; Kim HJ; Chima M; Lebwohl M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2019 Jun; 143(6):2095-2107. PubMed ID: 30576756
[TBL] [Abstract][Full Text] [Related]
15. Cytokines: the yin and yang of vitiligo pathogenesis.
Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
[TBL] [Abstract][Full Text] [Related]
16. Gene Co-expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Vitiligo Disease: A Systems Biology Study.
Derakhshani A; Mollaei H; Parsamanesh N; Fereidouni M; Miri-Moghaddam E; Nasseri S; Luo Y; Safarpour H; Baradaran B
Iran J Allergy Asthma Immunol; 2020 Oct; 19(5):517-528. PubMed ID: 33463119
[TBL] [Abstract][Full Text] [Related]
17. An Exploration of the Role of MicroRNAs in Psoriasis: A Systematic Review of the Literature.
Huang RY; Li L; Wang MJ; Chen XM; Huang QC; Lu CJ
Medicine (Baltimore); 2015 Nov; 94(45):e2030. PubMed ID: 26559308
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs: novel regulators in skin inflammation.
Sonkoly E; Ståhle M; Pivarcsi A
Clin Exp Dermatol; 2008 May; 33(3):312-5. PubMed ID: 18419608
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA profiling of psoriatic skin identifies 11 miRNAs associated with disease severity.
Solvin ÅØ; Chawla K; Olsen LC; Hegre SA; Danielsen K; Jenssen M; Furberg AS; Saunes M; Hveem K; Saetrom P; Løset M
Exp Dermatol; 2022 Apr; 31(4):535-547. PubMed ID: 34748247
[TBL] [Abstract][Full Text] [Related]
20. The attentive focus on T cell-mediated autoimmune pathogenesis of psoriasis, lichen planus and vitiligo.
Aghamajidi A; Raoufi E; Parsamanesh G; Jalili A; Salehi-Shadkami M; Mehrali M; Mohsenzadegan M
Scand J Immunol; 2021 Apr; 93(4):e13000. PubMed ID: 33190330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
